272 related articles for article (PubMed ID: 19237607)
1. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/β-catenin signaling.
Kim JT; Kim JW; Kang YH; Kim KD; Lee SJ; Choi SC; Kim KS; Chae SK; Kim JW; Lim JS; Lee HG
FEBS Lett; 2012 Nov; 586(22):3962-8. PubMed ID: 23068607
[TBL] [Abstract][Full Text] [Related]
3. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
5. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
6. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
8. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
[TBL] [Abstract][Full Text] [Related]
9. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
11. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
12. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
Vietor I; Kurzbauer R; Brosch G; Huber LA
J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
[TBL] [Abstract][Full Text] [Related]
14. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
16. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
[TBL] [Abstract][Full Text] [Related]
17. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.
Shi H; Jin H; Chu D; Wang W; Zhang J; Chen C; Xu C; Fan D; Yao L
Biol Pharm Bull; 2009 Jun; 32(6):968-75. PubMed ID: 19483300
[TBL] [Abstract][Full Text] [Related]
18. TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans.
Anwar M; Malhotra P; Kochhar R; Bhatia A; Mahmood A; Singh R; Mahmood S
Cell Mol Biol Lett; 2020; 25():24. PubMed ID: 32265994
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
Wang Q; Sun ZX; Allgayer H; Yang HS
Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
[TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
